Imagen Biotech

ERT opening Innovation Lab in Boston

Monday, February 8, 2016

ERT is launching an Innovation Lab in Boston on February 9. A cloud platform solutions provider, ERT supplies the industry, sponsors and CROs alike, with technology, services and consultancy. The company is known for first-in-the-industry features such as wireless eDiaries to collect electronic Clinical Outcome Assessments (eCOA).

[Read More]

Imagen Biotech secures $40 million in Series A financing

Thursday, October 20, 2011

Imagen Biotech has secured up to $40 million in Series A financing from SV Life Sciences, Novo Ventures, and Fidelity Biosciences to pursue the identification and development of breakthrough treatments for blinding diseases with high unmet medical needs, including dry age-related macular degeneration. Matthew Feinsod, MD, an ophthalmologist who was formerly at Eyetech Pharmaceuticals and a medical officer in the FDA’s Ophthalmology Division, will lead these efforts as chief medical officer for Imagen. Additional terms will not be disclosed.

[Read More]